These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6212098)

  • 1. [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits].
    Elsair J; Marquie G; Drif M; Khelfat K; Benouniche N; Tabet Aoul M; Tabet Aoul FS; Iklef F; Ghouini A
    C R Seances Soc Biol Fil; 1982; 176(2):140-5. PubMed ID: 6212098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of clofibride on the lipolysis of perirenal adipose tissue in hyperlipemic rabbits].
    Elsair J; Marquie G; Tabet Aoul M; Dahmani Y; Tabet Aoul FS; Dufour P; Khelfat K; Iklef F; Ghouini A
    C R Seances Soc Biol Fil; 1982; 176(2):146-50. PubMed ID: 6212099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of clofibride in the rabbit or in normal man, at the beginning or after 15 days of treatment. Effects on plasma lipids in the hours following its administration during fasting, without heparin or during heparin-clearing factor induction].
    Elsair J; Drif M; Merad R; Denine R; Khelfat K; Benouniche N; Reggabi M; Alamir B
    Biomedicine; 1979 Nov; 30(5):249-56. PubMed ID: 518959
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of simfibrate on post-heparin lipoprotein lipase].
    Cavallini L; Lucchetti G; Marchi S; Guglielmini R
    Clin Ter; 1980 Jan; 92(1):25-31. PubMed ID: 7004746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
    Davies JE; Kellett DN
    Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Potentiating of lipid lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
    Simane Z; Nowak H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R94. PubMed ID: 4276652
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dyslipidemia characteristics in arterial hypertension].
    Neverov IV; Baĭmatova DD
    Sov Med; 1984; (6):46-9. PubMed ID: 6379903
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV; Metz G
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
    Metz G; Specker M
    Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma post-heparin lipolytic activity in hyperchylomi-cronemia (fat-induced lipemia).
    Bradford RH; Furman RH; Bass HB
    Biochim Biophys Acta; 1968 Oct; 164(2):172-84. PubMed ID: 5721021
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship between lipemia and sensitivity to arachidonic acid in rabbits].
    Deby C; Deby-Dupont G; Bourdon-Neuray J; Simon D
    C R Seances Soc Biol Fil; 1978; 172(5):1017-24. PubMed ID: 157189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypolipemic activity of plafibride.
    Bruseghini L; Vilageliu J; Bagaria A
    Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
    Adameová A; Kuzelová M; Faberová V; Svec P
    Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ginsenosides from stems and leaves on hyperlipemia induced by prednisone acetate in rabbits].
    Wen Y; Pei Y; Chen Y; Wang Z; Ma Z; Wang M; Li W
    Zhongguo Zhong Yao Za Zhi; 1996 Jul; 21(7):430-1, 448. PubMed ID: 9642397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.